SC
PTCT icon

Steven Cohen’s PTC Therapeutics PTCT Stock Holding History

Steven Cohen’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-250,000
Closed -$12.7M – 1067
2020
Q2 		$12.7M Sell
250,000
-700,000
-74% -$34.4M 0.08% 282
2020
Q1 		$42.4M Buy
950,000
+550,000
+138% +$27.7M 0.34% 72
2019
Q4 		$19.2M Hold
400,000
– – 0.1% 263
2019
Q3 		$13.5M Buy
+400,000
New +$17.4M 0.08% 290
2015
Q4 		– Sell
-250,000
Closed -$6.67M – 807
2015
Q3 		$6.67M Buy
+250,000
New +$10.7M 0.05% 380

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Steven Cohen's PTCT Position: Q1 2026 in Review

Steven Cohen sold out of PTC Therapeutics (PTCT) in Q1 2026, closing a stake of 1,128,551 shares — an estimated $85.7M sold.

Steven Cohen first reported a position in PTCT in Q3 2014 and held it in 29 quarters. The position peaked at $119M in Q2 2019. 351 funds tracked by Wall St. Rank hold PTCT as of Q1 2026.

  • Steven Cohen reported no remaining PTC Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Steven Cohen sold 1,128,551 PTC Therapeutics shares in Q1 2026, an estimated $85.7M.
  • Steven Cohen first reported a position in PTC Therapeutics in Q3 2014 and held it in 29 quarters.
  • Steven Cohen's PTC Therapeutics position peaked at $119M in Q2 2019.
  • 351 funds tracked by Wall St. Rank held PTC Therapeutics as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.